Claeson G, Friberger P, Knös M, Eriksson E
Haemostasis. 1978;7(2-3):76-8. doi: 10.1159/000214238.
New chromogenic tripeptide substrates have been used for the determination of kallikreins and urokinase. The conditions have been optimized. It is possible to determine prekallikrein in plasma after activation with Cephotest. No significant loss in activity caused by plasma kallikrein inhibitors is observed at the dilutions used.
新型显色三肽底物已用于激肽释放酶和尿激酶的测定。条件已得到优化。在用Cephotest激活后,可以测定血浆中的前激肽释放酶。在所使用的稀释度下,未观察到血浆激肽释放酶抑制剂导致的活性显著损失。